Ixazomib citrate (Standard)

Overview

Ixazomib citrate (Standard) is the analytical standard of Ixazomib citrate ( HY-10452 ). This product is intended for research and analytical applications. Ixazomib citrate (MLN9708) is a selective, orally active, second-generation proteasome inhibitor . Ixazomib citrate can be used for the study of a broad range of human malignancies.

Application

Products | Products > Signaling Pathways > Metabolic Enzyme/Protease | Products > Signaling Pathways > Others | Products > Signaling Pathways > Autophagy | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Signaling Pathways > Proteasome | Products > Signaling Pathways > Reference Standards | Products > Signaling Pathways > Autophagy

Product Information

• Catalog No.: HY-10452R
• CAS No.: 1239908-20-3
• Molecular Formula: C20H23BCl2N2O9
• Molecular Weight: 517.12
• Purity: 95%
• Storage: Please store the product under the recommended conditions in the Certificate of Analysis.
• Availability: In-stock

Source

Original product source